Abstract
In recent years, CRISPR–Cas9 technology is widely acknowledged for having major applications in the field of biotechnology for editing genome of any organism to treat a variety of complex diseases and for other purposes. The acronym ‘CRISPR–Cas’ stands for clustered regularly interspaced short palindromic repeats–CRISPR-associated genes. This genetic organization exists in prokaryotic organisms and aids in the development of adaptive immunity since a protein called Cas9 nuclease cleaves specific target nucleic acid sequences from foreign invaders and destroys them. This mode of action has gained interest of the researchers to understand the insights of CRISPR–Cas9 technology. Here, we review that CRISPR–Cas organization is restricted to two classes and possesses different protein effectors. We also review the architecture of CRISPR loci, mechanism involved in genome editing by CRISPR–Cas9 technology and pathways of repairing double-strand breaks (DSBs) generated during the process of genome editing. This review also presents the strategies to increase the Cas9 specificity and reduce off-target activity to achieve accurate genome editing. Further, this review provides information on CRISPR tools used for genome editing, databases that are required for storing data on loci, strategies for delivering CRISPR–Cas9 to cells under study and applications of CRISPR–Cas9 to various fields. Safety measures are implemented on this technology to avoid misuse or ethical issues. We also discuss about the future aspects and potential applications of CRISPR–Cas9 technology required mainly for the treatment of dreadful diseases, crop improvement as well as genetic improvement in human.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abudayyeh OO et al (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353(6299):5573
Abudayyeh OO et al (2017) RNA targeting with CRISPR–Cas13. Nature 550(7675):280
Adames NR, Gallegos JE, Peccoud J (2019) Yeast genetic interaction screens in the age of CRISPR/Cas. Curr Genet 65(2):307–327
Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9(1):1911
Aman R et al (2018) RNA virus interference via CRISPR/Cas13a system in plants. Genome Biol 19(1):1
Amitai G, Sorek R (2016) CRISPR–Cas adaptation: insights into the mechanism of action. Nat Rev Microbiol 14(2):67
Anders C et al (2014) Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513(7519):569
Annunziato S et al (2016) Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland. Genes Dev 30(12):1470–1480
Bae S et al (2014) Microhomology-based choice of Cas9 nuclease target sites. Nat Methods 11(7):705
Barrangou R (2015) Diversity of CRISPR–Cas immune systems and molecular machines. Genome Biol 16(1):247
Barrangou R, Doudna JA (2016) Applications of CRISPR technologies in research and beyond. Nat Biotechnol 34(9):933
Barrangou R, Marraffini LA (2014) CRISPR–Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 54(2):234–244
Barrangou R et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819):1709–1712
Beisel CL, Gomaa AA, Barrangou R (2014) A CRISPR design for next-generation antimicrobials. Genome Biol 15(11):516
Blin K et al (2016) CRISPy-web: an online resource to design sgRNAs for CRISPR applications. Synth Syst Biotechnol 1(2):118–121
Bolotin A et al (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151(8):2551–2561
Bult CJ et al (1996) Complete genome sequence of the Methanogenic archaeon, Methanococcus jannaschii. Science 273(5278):1058–1073
Burger C, Nash K, Mandel RJ (2005) Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 16(7):781–791
Carroll D (2011) Genome engineering with zinc-finger nucleases. Genetics 188(4):773–782
Charpentier E, Marraffini LA (2014) Harnessing CRISPR–Cas9 immunity for genetic engineering. Curr Opin Microbiol 19:114–119
Chen B et al (2013) Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155(7):1479–1491
Chen C et al (2014) MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell 25(5):652–665
Chen S et al (2015) Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160(6):1246–1260
Chen JS et al (2017) Enhanced proofreading governs CRISPR–Cas9 targeting accuracy. Nature 550(7676):407
Chiou S-H et al (2015) Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev 29(14):1576–1585
Cho SW et al (2014) Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24(1):132–141
Chow RD et al (2017) AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci 20(10):1329
Chylinski K et al (2014) Classification and evolution of type II CRISPR–Cas systems. Nucleic Acids Res 42(10):6091–6105
Clement K et al (2019) CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol 37(3):224
Cobb RE, Wang Y, Zhao H (2014) High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth Biol 4(6):723–728
Cong L et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819–823
Cox DBT, Platt RJ, Zhang F (2015) Therapeutic genome editing: prospects and challenges. Nat Med 21(2):121
Cradick TJ et al (2014) COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites. Mol Ther Nucleic Acids 3:e214
Deans RM et al (2016) Parallel shRNA and CRISPR–Cas9 screens enable antiviral drug target identification. Nat Chem Biol 12(5):361
Deltcheva E et al (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340):602
Deveau H et al (2008) Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190(4):1390–1400
Deveau H, Garneau JE, Moineau S (2010) CRISPR/Cas system and its role in phage–bacteria interactions. Annu Rev Microbiol 64:475–493
Dianov GL, Hübscher U (2013) Mammalian base excision repair: the forgotten archangel. Nucleic Acids Res 41(6):3483–3490
Díez-Villaseñor C et al (2010) Diversity of CRISPR loci in Escherichia coli. Microbiology 156(5):1351–1361
Ding Q et al (2013) Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12(4):393–394
Dong C et al (2015) Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Antiviral Res 118:110–117
Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR–Cas9. Science 346(6213):1258096
Elison GL, Acar M (2018) Scarless genome editing: progress towards understanding genotype–phenotype relationships. Curr Genet 64(6):1229–1238
Enkler L et al (2016) Genome engineering in the yeast pathogen Candida glabrata using the CRISPR–Cas9 system. Sci Rep 6:35766
Eyquem J et al (2017) Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature 543(7643):113
Fellmann C et al (2017) Cornerstones of CRISPR–Cas in drug discovery and therapy. Nat Rev Drug Discov 16(2):89
Feng Z et al (2014) Multigeneration analysis reveals the inheritance, specificity, and patterns of CRISPR/Cas-induced gene modifications in Arabidopsis. Proc Natl Acad Sci 111(12):4632–4637
Firth AL et al (2015) Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep 12(9):1385–1390
Fu Y et al (2013) High-frequency off-target mutagenesis induced by CRISPR–Cas nucleases in human cells. Nat Biotechnol 31(9):822
Fuller KK et al (2015) Development of the CRISPR/Cas9 system for targeted gene disruption in Aspergillus fumigatus. Eukaryot Cell 14(11):1073–1080
Gaj T, Gersbach CA, Barbas CF III (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397–405
Garneau JE et al (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468(7320):67
Gasiunas G et al (2012) Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci 109(39):E2579–E2586
Ghezraoui H et al (2014) Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell 55(6):829–842
Gilbert LA et al (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154(2):442–451
Gilbert LA et al (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159(3):647–661
Gilles AF, Averof M (2014) Functional genetics for all: engineered nucleases, CRISPR and the gene editing revolution. EvoDevo 5(1):43
Gootenberg JS et al (2017) Nucleic acid detection with CRISPR–Cas13a/C2c2. Science 356(6336):438–442
Grahl N et al (2017) Use of RNA–protein complexes for genome editing in non-albicans Candida species. mSphere 2(3):e00218–e00317
Grissa I, Vergnaud G, Pourcel C (2007) The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinform 8(1):172
Groenen PM et al (1993) Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol Microbiol 10(5):1057–1065
Guilinger JP, Thompson DB, Liu DR (2014) Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32(6):577
Heckl D et al (2014) Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR–Cas9 genome editing. Nat Biotechnol 32(9):941
Heidenreich M, Zhang F (2016) Applications of CRISPR–Cas systems in neuroscience. Nat Rev Neurosci 17(1):36
Heigwer F, Kerr G, Boutros M (2014) E-CRISP: fast CRISPR target site identification. Nat Methods 11(2):122
Heler R et al (2015) Cas9 specifies functional viral targets during CRISPR–Cas adaptation. Nature 519(7542):199
Hodgkins A et al (2015) WGE: a CRISPR database for genome engineering. Bioinformatics 31(18):3078–3080
Hoe N et al (1999) Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis 5(2):254
Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327(5962):167–170
Hou P et al (2015) Genome editing of CXCR189 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci Rep 5:15577
Hsu PD et al (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31(9):827
Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR–Cas9 for genome engineering. Cell 157(6):1262–1278
Hu Z, Yu L, Zhu D, Ding W, Wang X, Zhang C, Wang L, Jiang X, Shen H, He D, Li K, Xi L, Ma D, Wang H (2014a) Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. BioMed Res Int. https://doi.org/10.1155/2014/612823
Hu W et al (2014) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci 111(31):11461–11466
Huang H et al (2016) CRISPR/Cas9-based efficient genome editing in Clostridium ljungdahlii, an autotrophic gas-fermenting bacterium. ACS Synth Biol 5(12):1355–1361
Hur JK et al (2016) Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat Biotechnol 34(8):807
Ishino Y et al (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169(12):5429–5433
Jansen R et al (2002) Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43(6):1565–1575
Jia H, Wang N (2014) Targeted genome editing of sweet orange using Cas9/sgRNA. PLoS One 9(4):e93806
Jiang W et al (2013) RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nat Biotechnol 31(3):233
Jinek M et al (2012a) A programmable dual-RNA—guided DNA endonuclease in adaptive bacterial immunity. Science 337:816
Jinek M et al (2012b) A programmable dual-RNA—guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816–821
Jinek M et al (2013) RNA-programmed genome editing in human cells. Life 2:00471
Jinek M et al (2014) Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343(6176):1247997
Kampmann M, Bassik MC, Weissman JS (2014) Functional genomics platform for pooled screening and generation of mammalian genetic interaction maps. Nat Protoc 9(8):1825
Kampmann M et al (2015) Next-generation libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci 112(26):E3384–E3391
Kennedy EM, Cullen BR (2015) Bacterial CRISPR/Cas DNA endonucleases: a revolutionary technology that could dramatically impact viral research and treatment. Virology 479:213–220
Kennedy EM et al (2014) Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. J Virol 88(20):11965–11972
Kennedy EM et al (2015) Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease. Virology 476:196–205
Kim Y et al (2016a) Generation of knockout mice by Cpf1-mediated gene targeting. Nat Biotechnol 34(8):808
Kim D et al (2016b) Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol 34(8):863
Kim H et al (2017) CRISPR/Cpf1-mediated DNA-free plant genome editing. Nat Commun 8:14406
Kleinstiver BP et al (2016a) Genome-wide specificities of CRISPR–Cas Cpf1 nucleases in human cells. Nat Biotechnol 34(8):869
Kleinstiver BP et al (2016b) High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529(7587):490
Knott GJ, Doudna JA (2018) CRISPR–Cas guides the future of genetic engineering. Science 361(6405):866–869
Koike-Yusa H et al (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32(3):267
Koonin EV, Makarova KS, Zhang F (2017) Diversity, classification and evolution of CRISPR–Cas systems. Curr Opin Microbiol 37:67–78
Labun K et al (2016) CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res 44(W1):W272–W276
Legut M et al (2018) CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells. Blood 131(3):311–322
Lei Y et al (2014) CRISPR-P: a web tool for synthetic single-guide RNA design of CRISPR-system in plants. Mol Plant 7(9):1494–1496
Lenoir WF, Lim TL, Hart T (2017) PICKLES: the database of pooled in vitro CRISPR knockout library essentiality screens. Nucleic Acids Res 46(D1):D776–D780
Li J-F et al (2013) Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol 31(8):688
Li W et al (2014) MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol 15(12):554
Li C et al (2015) Inhibition of HIV-1 infection of primary CD4 + T-cells by gene editing of CCR185 using adenovirus-delivered CRISPR/Cas9. J Gen Virol 96(8):2381–2393
Liang G et al (2016) Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing. Sci Rep 6:21451
Lieber MR et al (2003) Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4(9):712
Lin S-R et al (2014) The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids 3:e186
Liu R et al (2015a) Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system. Cell Discov 1:15007
Liu X et al (2015b) Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome. J Gen Virol 96(8):2252–2261
Liu Q et al (2017a) Development of a genome-editing CRISPR/Cas9 system in thermophilic fungal Myceliophthora species and its application to hyper-cellulase production strain engineering. Biotechnol Biofuels 10(1):1
Liu H et al (2017b) CRISPR-P 2.0: an improved CRISPR–Cas9 tool for genome editing in plants. Mol Plant 10(3):530–532
Long C et al (2014) Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA. Science 345(6201):1184–1188
Long C et al (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351(6271):400–403
Makarova KS et al (2011a) Evolution and classification of the CRISPR–Cas systems. Nat Rev Microbiol 9(6):467
Makarova KS et al (2011b) Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR–Cas systems. Biol Direct 6(1):38
Makarova KS, Wolf YI, Koonin EV (2013) The basic building blocks and evolution of CRISPR–Cas systems. Portland Press Limited, London
Makarova KS et al (2015) An updated evolutionary classification of CRISPR–Cas systems. Nat Rev Microbiol 13(11):722
Mali P et al (2013a) RNA-guided human genome engineering via Cas9. Science 339(6121):823–826
Mali P et al (2013b) CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31(9):833
Malina A et al (2014) Adapting CRISPR/Cas9 for functional genomics screens. Methods in enzymology. Elsevier, Amsterdam, pp 193–213
Marceau CD et al (2016) Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature 535(7610):159
Marraffini LA, Sontheimer EJ (2010) CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11(3):181
Masepohl B, Görlitz K, Böhme H (1996) Long tandemly repeated repetitive (LTRR) sequences in the filamentous cyanobacterium Anabaena sp. PCC 7120. Biochim Biophys Acta (BBA) Gene Struct Expr 1307(1):26–30
Mendell JR, Rodino-Klapac LR (2016) Duchenne muscular dystrophy: CRISPR/Cas9 treatment. Cell Res 26(5):513
Meng X et al (2017) Construction of a genome-wide mutant library in rice using CRISPR/Cas9. Mol Plant 10(9):1238–1241
Miao J et al (2013) Targeted mutagenesis in rice using CRISPR–Cas system. Cell Res 23(10):1233
Min K et al (2016) Candida albicans gene deletion with a transient CRISPR–Cas9 system. mSphere 1(3):e00130–e00216
Mojica F et al (1995) Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol 17(1):85–93
Mojica FJ, García-Martínez J, Soria E (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60(2):174–182
Mojica FJ et al (2009) Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155(3):733–740
Monteys AM et al (2017) CRISPR/Cas9 editing of the mutant huntingtin allele in vitro and in vivo. Mol Ther 25(1):12–23
Moreno-Mateos MA et al (2017) CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing. Nat Commun 8(1):2024
Nagaraju S et al (2016) Genome editing of Clostridium autoethanogenum using CRISPR/Cas9. Biotechnol Biofuels 9(1):219
Nelson KE et al (1999) Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature 399(6734):323
Nelson CE et al (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351(6271):403–407
Nelson CE, Robinson-Hamm JN, Gersbach CA (2017) Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nat Rev Neurol 13(11):647
Nishimasu H et al (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156(5):935–949
O’Rourke KP et al (2017) Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat Biotechnol 35(6):577
Osborn MJ et al (2014) Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther 26(2):114–126
Park J, Bae S, Kim J-S (2015) Cas-Designer: a web-based tool for choice of CRISPR–Cas9 target sites. Bioinformatics 31(24):4014–4016
Pawluk A et al (2016) Naturally occurring off-switches for CRISPR–Cas9. Cell 167(7):1829–1838
Peng D, Tarleton R (2015) EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens. Microb Genom 1(4):e000033. https://doi.org/10.1099/mgen.0.000033
Perez-Pinera P et al (2013) RNA-guided gene activation by CRISPR–Cas9—based transcription factors. Nat Methods 10(10):973
Petris G et al (2017) Hit and go CAS9 delivered through a lentiviral based self-limiting circuit. Nat Commun 8:15334
Platt RJ et al (2014) CRISPR–Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2):440–455
Polstein LR, Gersbach CA (2015) A light-inducible CRISPR–Cas9 system for control of endogenous gene activation. Nat Chem Biol 11(3):198
Port F, Bullock SL (2016) Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs. Nat Methods 13(10):852
Pougach K et al (2010) Transcription, processing and function of CRISPR cassettes in Escherichia coli. Mol Microbiol 77(6):1367–1379
Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151(3):653–663
Prykhozhij SV et al (2015) CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences. PLoS One 10(3):e0119372
Puschnik AS et al (2017) A CRISPR toolbox to study virus–host interactions. Nat Rev Microbiol 15(6):351
Qi LS et al (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152(5):1173–1183
Ramanan V et al (2015) CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Sci Rep 5:10833
Ran FA et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380–1389
Rauscher B, Heigwer F, Breinig M, Winter J, Boutros M (2016) GenomeCRISPR-a database for high-throughput CRISPR/Cas9 screens. Nucleic Acids Res. https://doi.org/10.1093/nar/gkw997
Ren X et al (2014) Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep 9(3):1151–1162
Ren J et al (2017) Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin Cancer Res 23(9):2255–2266
Rogers ZN et al (2017) A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods 14(7):737
Rogers ZN et al (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50(4):483
Ronda C et al (2014) Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool. Biotechnol Bioeng 111(8):1604–1616
Roper J et al (2017) In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol 35(6):569
Rousseau C et al (2009) CRISPI: a CRISPR interactive database. Bioinformatics 25(24):3317–3318
Sánchez-Rivera FJ, Jacks T (2015) Applications of the CRISPR–Cas9 system in cancer biology. Nat Rev Cancer 15(7):387
Sánchez-Rivera FJ et al (2014) Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516(7531):428
Sander JD, Joung JK (2014) CRISPR–Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4):347
Sapranauskas R et al (2011) The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 39(21):9275–9282
Schwank G et al (2013) Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13(6):653–658
Shalem O et al (2014) Genome-scale CRISPR–Cas9 knockout screening in human cells. Science 343(6166):84–87
Shalem O, Sanjana NE, Zhang F (2015) High-throughput functional genomics using CRISPR–Cas9. Nat Rev Genet 16(5):299
Shan Q et al (2013) Targeted genome modification of crop plants using a CRISPR–Cas system. Nat Biotechnol 31(8):686
Shin JW et al (2016) Permanent inactivation of Huntington’s disease mutation by personalized allele-specific CRISPR/Cas9. Hum Mol Genet 25(20):4566–4576
Shmakov S et al (2015) Discovery and functional characterization of diverse class 2 CRISPR–Cas systems. Mol Cell 60(3):385–397
Shmakov S et al (2017) Diversity and evolution of class 2 CRISPR–Cas systems. Nat Rev Microbiol 15(3):169
Slaymaker IM et al (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351(6268):84–88
Smargon AA et al (2017) Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol Cell 65(4):618–630
Soreanu I et al (2018) Marker-free genetic manipulations in yeast using CRISPR/CAS9 system. Curr Genet 64(5):1129–1139
Stemmer M et al (2015) CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLoS One 10(4):e0124633
Sternberg SH et al (2014) DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507(7490):62
Straub C et al (2014) CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons. PLoS One 9(8):e105584
Strong A, Musunuru K (2017) Genome editing in cardiovascular diseases. Nat Rev Cardiol 14(1):11
Swarts DC, Jinek M (2018) Cas9 versus Cas12a/Cpf1: structure–function comparisons and implications for genome editing. Wiley Interdiscip Rev RNA 9(5):e1481
Świat MA et al (2017) FnCpf1: a novel and efficient genome editing tool for Saccharomyces cerevisiae. Nucleic Acids Res 45(21):12585–12598
Szczelkun MD et al (2014) Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. Proc Natl Acad Sci 111(27):9798–9803
Tabebordbar M et al (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351(6271):407–411
Tang X et al (2017) A CRISPR–Cpf1 system for efficient genome editing and transcriptional repression in plants. Nat Plants 3(3):17018
Taymans J-M et al (2007) Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18(3):195–206
Terns MP, Terns RM (2011) CRISPR-based adaptive immune systems. Curr Opin Microbiol 14(3):321–327
Tsai SQ et al (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32(6):569
Van der Oost J et al (2009) CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 34(8):401–407
Van Der Oost J et al (2014) Unravelling the structural and mechanistic basis of CRISPR–Cas systems. Nat Rev Microbiol 12(7):479
Varshney GK et al (2015) CRISPRz: a database of zebrafish validated sgRNAs. Nucleic Acids Res 44(D1):D822–D826
Vaschetto LM (2018) Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion. Curr Genet 64(2):405–412
Vyas VK, Barrasa MI, Fink GR (2015) A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv 1(3):e1500248
Walter DM et al (2017) Systematic in vivo inactivation of chromatin-regulating enzymes identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma. Cancer Res 77(7):1719–1729
Wang J, Quake SR (2014) RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc Natl Acad Sci 111(36):13157–13162
Wang T et al (2014a) Genetic screens in human cells using the CRISPR–Cas9 system. Science 343(6166):80–84
Wang W et al (2014b) CCR186 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One 9(12):e115987
Wang D et al (2015a) Adenovirus-mediated somatic genome editing of Pten by CRISPR/Cas9 in mouse liver in spite of Cas9-specific immune responses. Hum Gene Ther 26(7):432–442
Wang J et al (2015b) Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication. World J Gastroenterol 21(32):9554
Wang H, La Russa M, Qi LS (2016a) CRISPR/Cas9 in genome editing and beyond. Annu Rev Biochem 85:227–264
Wang Y et al (2016b) Bacterial genome editing with CRISPR–Cas9: deletion, integration, single nucleotide modification, and desirable “clean” mutant selection in Clostridium beijerinckii as an example. ACS Synth Biol 5(7):721–732
Wei Y et al (2015a) Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus. Nucleic Acids Res 43(3):1749–1758
Wei Y, Terns RM, Terns MP (2015b) Cas9 function and host genome sampling in type II-A CRISPR–Cas adaptation. Genes Dev 29(4):356–361
Westra ER et al (2010) H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO. Mol Microbiol 77(6):1380–1393
Westra ER et al (2013) Type IE CRISPR–Cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet 9(9):e1003742
Wilkinson RA, Martin C, Nemudryi AA, Wiedenheft B (2019) CRISPR RNA-guided autonomous delivery of Cas9. Nat Struct Mol Biol 26(1):14–24
Winters IP et al (2017) Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nat Commun 8(1):2053
Wong N, Liu W, Wang X (2015) WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system. Genome Biol 16(1):218
Wu Y et al (2013) Correction of a genetic disease in mouse via use of CRISPR–Cas9. Cell Stem Cell 13(6):659–662
Wu X et al (2014) Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 32(7):670
Xie K, Yang Y (2013) RNA-guided genome editing in plants using a CRISPR–Cas system. Mol Plant 6(6):1975–1983
Xiong X et al (2016) CRISPR/Cas9 for human genome engineering and disease research. Annu Rev Genom Hum Genet 17:131–154
Xu X et al (2017) Reversal of phenotypic abnormalities by CRISPR/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep 8(3):619–633
Yang L et al (2015) Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science 350(6264):1101–1104
Ye L et al (2014) Seamless modification of wild-type induced pluripotent stem cells to the natural CCR187Δ32 mutation confers resistance to HIV infection. Proc Natl Acad Sci 111(26):9591–9596
Yin H, Kauffman KJ, Anderson DG (2017a) Delivery technologies for genome editing. Nat Rev Drug Discov 16(6):387
Yin K, Gao C, Qiu J-L (2017b) Progress and prospects in plant genome editing. Nat Plants 3(8):17107
Yin H, Xue W, Anderson DG (2019) CRISPR–Cas: a tool for cancer research and therapeutics. Nat Rev Clin Oncol 16:281
Yosef I, Goren MG, Qimron U (2012) Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 40(12):5569–5576
Zetsche B et al (2015a) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system. Cell 163(3):759–771
Zetsche B, Volz SE, Zhang F (2015b) A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33(2):139
Zetsche B et al (2017) Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array. Nat Biotechnol 35(1):31
Zhang S, Sodroski J (2015) Efficient human immunodeficiency virus (HIV-1) infection of cells lacking PDZD8. Virology 481:73–78
Zhang F et al (2018) CRISPRminer is a knowledge base for exploring CRISPR–Cas systems in microbe and phage interactions. Commun Biol 1(1):180
Zhen S et al (2015) Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus. Gene Ther 22(5):404
Zhou Y et al (2014) High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509(7501):487
Zhu LJ et al (2014) CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR–Cas9 genome-editing systems. PLoS One 9(9):e108424
Zhu S et al (2016) Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library. Nat Biotechnol 34(12):1279
Zuckermann M et al (2015) Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun 6:7391
Acknowledgements
We are grateful to Assam University, Silchar, Assam, India, for providing necessary facilities for this review work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest in this work.
Additional information
Communicated by M. Kupiec.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Barman, A., Deb, B. & Chakraborty, S. A glance at genome editing with CRISPR–Cas9 technology. Curr Genet 66, 447–462 (2020). https://doi.org/10.1007/s00294-019-01040-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00294-019-01040-3